69 related articles for article (PubMed ID: 2532701)
1. Carbonic anhydrase III and collagen markers in serum following cross-country skiing.
Takala TE; Vuori JJ; Rahkila PJ; Hakala EO; Karpakka JA; Alen MJ; Orava YS; Väänänen HK
Med Sci Sports Exerc; 1989 Oct; 21(5):593-7. PubMed ID: 2532701
[TBL] [Abstract][Full Text] [Related]
2. Prolonged exercise causes an increase in the activity of galactosylhydroxylysyl glucosyltransferase and in the concentration of type III procollagen aminopropeptide in human serum.
Takala TE; Vuori J; Anttinen H; Väänänen K; Myllylä R
Pflugers Arch; 1986 Nov; 407(5):500-3. PubMed ID: 2947039
[TBL] [Abstract][Full Text] [Related]
3. Serum carbonic anhydrase III in myotonic dystrophy.
Mokuno K; Riku S; Matsuoka Y; Kato K
Muscle Nerve; 1986; 9(3):257-60. PubMed ID: 3084971
[TBL] [Abstract][Full Text] [Related]
4. Two serum markers of collagen biosynthesis as possible indicators of irreversible pulmonary impairment in farmer's lung.
Anttinen H; Terho EO; Myllylä R; Savolainen ER
Am Rev Respir Dis; 1986 Jan; 133(1):88-93. PubMed ID: 2935059
[TBL] [Abstract][Full Text] [Related]
5. Serum enzymes of collagen synthesis and type III procollagen aminopropeptide in Nigerian patients with sickle cell disease.
Bolarin DM
J Natl Med Assoc; 1986 Jul; 78(7):613-6. PubMed ID: 3018272
[TBL] [Abstract][Full Text] [Related]
6. The aminoterminal propeptide of type III procollagen and basement membrane components in serum during wound healing in man.
Bentsen KD; Lanng C; Hørslev-Petersen K; Risteli J
Acta Chir Scand; 1988 Feb; 154(2):97-101. PubMed ID: 3354300
[TBL] [Abstract][Full Text] [Related]
7. Serum enzymes of collagen synthesis and type III procollagen amino-propeptide in Nigerian patients with sickle cell disease.
Bolarin M
J Clin Chem Clin Biochem; 1986 Jul; 24(7):433-6. PubMed ID: 3016143
[TBL] [Abstract][Full Text] [Related]
8. Serum aminoterminal type III procollagen peptide. Relation to biosynthesis of collagen type III in experimentally induced granulation tissue in rats.
Hørslev-Petersen K; Kim KY; Pedersen LR; Bentsen KD; Uldbjerg N; Oxlund H; Garbarsch C; Hahn EG; Schuppan D; Lorenzen I
APMIS; 1988 Sep; 96(9):793-804. PubMed ID: 3048338
[TBL] [Abstract][Full Text] [Related]
9. Human muscle carbonic anhydrase III (CA-III). Purification, immunohistochemical localization in the human skeletal muscle and its clinical application to the neuromuscular disease.
Shima K
Hokkaido Igaku Zasshi; 1984 Mar; 59(2):98-116. PubMed ID: 6430772
[TBL] [Abstract][Full Text] [Related]
10. [Changes in collagen biosynthesis in patients with hip joint replacement surgery and reoperation].
Becvár R; Myllylä R; Krbec M; Cech O; Adam M
Acta Chir Orthop Traumatol Cech; 1991 May; 58(3):178-84. PubMed ID: 1832808
[TBL] [Abstract][Full Text] [Related]
11. Type I and III collagen metabolites as predictors of clinical outcome in epithelial ovarian cancer.
Santala M; Simojoki M; Risteli J; Risteli L; Kauppila A
Clin Cancer Res; 1999 Dec; 5(12):4091-6. PubMed ID: 10632345
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of laminin P1 and aminoterminal propeptide of type III procollagen in sickle cell disease.
Bolarin DM; Swerdlow P; Wallace AM; Littsey L
Haematologia (Budap); 1998; 29(1):51-8. PubMed ID: 9704258
[TBL] [Abstract][Full Text] [Related]
13. [Clinical usefulness of cross-linked N-telopeptide of type I collagen (NTx) as a bone metastatic marker in patients with prostate cancer--comparison with serum PICP, PINP and ICTP].
Kobayashi Y; Ochi M; Tokue A
Hinyokika Kiyo; 2000 Dec; 46(12):869-72. PubMed ID: 11211802
[TBL] [Abstract][Full Text] [Related]
14. [Type III procollagen N-terminal peptide and type IV collagen-7S level in the serum and BALF of patients with non-Hodgkin's lymphoma before and after chemotherapy].
Niitsu N; Umeda M
Rinsho Ketsueki; 1994 Nov; 35(11):1267-75. PubMed ID: 7529840
[TBL] [Abstract][Full Text] [Related]
15. Effect of concentric exercise on serum muscle and collagen markers.
Virtanen P; Viitasalo JT; Vuori J; Väänänen K; Takala TE
J Appl Physiol (1985); 1993 Sep; 75(3):1272-7. PubMed ID: 8226540
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of selected parameters of collagen metabolism in patients with myopia].
Nowak M; Swietochowska E; Jochan K; Buntner B
Klin Oczna; 2000; 102(3):201-5. PubMed ID: 11126178
[TBL] [Abstract][Full Text] [Related]
17. Serum concentrations of type I collagen carboxyterminal telopeptide (ICTP) and type I procollagen carboxy-and aminoterminal propeptides (PICP, PINP) as markers of metastatic bone disease in breast cancer.
Tähtelä R; Thölix E
Anticancer Res; 1996; 16(4B):2289-93. PubMed ID: 8694558
[TBL] [Abstract][Full Text] [Related]
18. Biochemical markers of types I and III collagen and limited joint mobility in type 1 diabetic patients.
Arkkila PE; Koskinen PJ; Kantola IM; Rönnemaa T; Seppänen E; Viikari JS
Acta Diabetol; 2003 Dec; 40(4):151-5. PubMed ID: 14740273
[TBL] [Abstract][Full Text] [Related]
19. Liberation of muscle carbonic anhydrase into serum during extensive exercise.
Väänänen HK; Leppilampi M; Vuori J; Takala TE
J Appl Physiol (1985); 1986 Aug; 61(2):561-4. PubMed ID: 3091571
[TBL] [Abstract][Full Text] [Related]
20. Muscle-specific carbonic anhydrase III is a more sensitive marker of muscle damage than creatine kinase in neuromuscular disorders.
Väänänen HK; Takala TE; Tolonen U; Vuori J; Myllylä VV
Arch Neurol; 1988 Nov; 45(11):1254-6. PubMed ID: 3142447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
